CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease

✍ Scribed by Bruce L. Riser; Feridoon Najmabadi; Bernard Perbal; Darryl R. Peterson; Jo Ann Rambow; Melisa L. Riser; Ernest Sukowski; Herman Yeger; Sarah C. Riser

• Book ID: 117970843
• Publisher: American Society for Investigative Pathology
• Year: 2009
• Tongue: English
• Weight: 642 KB
• Volume: 174
• Category: Article
• ISSN: 0002-9440
• DOI: 10.2353/ajpath.2009.080241